Nitrofurantoin Orbit Pharma

Nitrofurantoin, the active ingredient in Nitrofurantoin Orbit Pharma, is a nitrofuran antibiotic presented as an oral dosage form for oral use. It treats uncomplicated urinary tract infections in adult patients by targeting common urinary pathogens. GNH USA supplies Nitrofurantoin Orbit Pharma as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Nitrofurantoin is used to manage infections of the urinary tract and related prophylaxis. - Uncomplicated urinary tract infection: eradicates susceptible uropathogens and relieves typical symptoms such as dysuria and frequency. - Acute cystitis: provides rapid bactericidal activity to clear infection in the bladder. - Recurrent urinary tract infection prophylaxis: reduces the frequency of future episodes when used as a preventive regimen.

Adverse reactions may range from mild to severe and should be monitored during therapy.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Loss of appetite: reduced desire to eat. - Headache: transient cranial discomfort. - Diarrhoea: loose stools, usually self‑limiting.

Serious or Rare Side Effects: - Pulmonary toxicity: interstitial lung disease or acute pneumonitis. - Hepatic injury: elevated liver enzymes or hepatitis. - Hemolytic anemia in G6PD deficiency: rapid destruction of red blood cells. - Severe allergic reactions: rash, angioedema, or anaphylaxis.

Nitrofurantoin requires careful assessment of patient factors and monitoring for adverse events. - Renal function assessment: avoid use in patients with creatinine clearance <60 mL/min. - G6PD deficiency: contraindicated due to risk of hemolysis. - Pulmonary monitoring: discontinue if cough, dyspnoea, or fever develop. - Duration limitation: limit therapy to the shortest effective course to reduce toxicity risk. - Pregnancy and lactation: category B, use only if clearly needed. - Store at ambient temperature below 25°C: keep in the original pack, protect from moisture.

Nitrofurantoin may interact with other medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Antacids containing magnesium or aluminium: reduce absorption of nitrofurantoin. - Probenecid: increases serum concentrations, raising toxicity risk. - Warfarin: may enhance anticoagulant effect, requiring INR monitoring. - Methenamine: concurrent use can diminish antibacterial activity.

Moderate Interactions (Monitor Closely): - Diuretics: increase risk of crystalluria, especially in dehydrated patients. - NSAIDs: potential additive renal impairment. - High‑dose Vitamin C: acidifies urine and may affect drug stability. - Ciprofloxacin: possible antagonistic effect on bacterial killing.